Is Canopy Growth (WEED) halal?
Canopy Growth (TSX: WEED) is a cannabis producer, and its adult-use (recreational) cannabis sales alone were about 29% of FY2025 net revenue. Under AAOIFI-style Shariah screening, that fails the business-activity gate: FAIL.
The two-gate Shariah screen
Every screener on this site runs the same two gates: first, the business must be halal (no conventional insurance, banking, alcohol, gambling, weapons manufacturing, and the like); second, the financial ratios must clear (debt under roughly 33% of market cap, non-compliant income under roughly 5%).
Gate one: the business — FAILED
Canopy Growth Corporation (TSX: WEED, Nasdaq: CGC) is a cannabis producer and marketer. In fiscal 2025 (ended March 31, 2025) it reported net revenue of C$268.9 million, of which C$195.5 million came from cannabis — Canada cannabis C$155.8 million (Canadian adult-use cannabis C$78.8 million, Canadian medical cannabis C$77.0 million) and international markets cannabis C$39.7 million — plus C$73.4 million from Storz & Bickel vaporizers, which are primarily cannabis consumption devices. Adult-use (recreational) cannabis alone accounted for about 29% of net revenue (C$78.8 million of C$268.9 million). Under AAOIFI-style Shariah screening, the production and sale of intoxicants is a prohibited business activity; a company whose core business is recreational cannabis does not pass the business-activity screen, regardless of any tolerance discussion around the medical segment. Facts only, no fatwa: this is the standard business-activity gate this site applies.
Gate two: the ratios — FAILED (moot — gate one already failed)
Because the stock fails at the business-activity gate, the financial ratios do not change the result — but they are reported anyway for completeness. Total debt was C$304 million at March 31, 2025 (FY2025 results release). The most recent filing, the Q1 FY2027 interim financial statements (June 30, 2026), reports debt principal of C$285.4 million (C$230.4 million loan agreement plus C$55.0 million convertible debenture). Against a market capitalization of about C$568.5 million (Finnhub, September 2026), that is roughly 50% debt-to-market-cap, above the ~33% ceiling. The non-compliant income ratio was not separately verified because the stock already fails gate one. All figures are recomputed from the cited sources.
What other screeners say
At screening time (September 29, 2026), no current public Shariah rating for Canopy Growth (WEED) was found on the Zoya, Musaffa, or ShariaPortfolio public pages — honestly reported as absent rather than invented. The FAIL recorded here rests on the company's own reported revenue mix, not on any third-party rating.
The bottom line
Canopy Growth (WEED) fails the Shariah screen at gate one: it is a cannabis producer earning roughly 29% of net revenue from adult-use (recreational) cannabis — an intoxicant business. Its debt ratio (~50% of market cap) would also exceed the ~33% ceiling. This screener records a FAIL based on facts from the company's own filings.
Sources
- Canopy Growth — Q4 & FY2025 results (official press release, canopygrowth.com)
- Canopy Growth — Q1 FY2027 interim financial statements, debt note (canopygrowth.com PDF)
- Finnhub — Canopy Growth (WEED.TO) market data, market cap ~C$568.5M
Frequently asked questions
Is Canopy Growth (WEED) halal?
No — Canopy Growth (WEED) gets a FAIL. It is a cannabis producer, and in FY2025 adult-use (recreational) cannabis alone was C$78.8 million of C$268.9 million net revenue, about 29%. The production and sale of intoxicants is a prohibited business activity under AAOIFI-style screening, so the stock fails at the business-activity gate.
But Canopy sells medical cannabis — does that make it compliant?
No. Canopy's medical cannabis revenue (C$77.0 million in FY2025) is separate from its adult-use (recreational) cannabis revenue (C$78.8 million). The screener judges the company, and the recreational share — about 29% of net revenue — is a core business line, far above any de minimis discussion. Whether medical cannabis use is permissible in specific circumstances is a question for a qualified scholar.
What is Canopy Growth's debt-to-market-cap ratio?
Roughly 50%. The company's Q1 FY2027 interim financial statements (June 30, 2026) report debt principal of C$285.4 million (C$230.4 million loan agreement plus C$55.0 million convertible debenture), against a market capitalization of about C$568.5 million (Finnhub, September 2026). That is above the ~33% ceiling — though the stock already fails at the business-activity gate, so the ratio does not change the result.
Do Zoya, Musaffa, or ShariaPortfolio rate Canopy Growth?
At screening time (September 29, 2026), no current public rating for Canopy Growth (WEED) was found on the Zoya, Musaffa, or ShariaPortfolio public pages. Third-party coverage was checked and honestly reported as absent.
What about Canopy Growth's dividend — does it need purification?
The company paid no dividend recently (Canopy Growth is unprofitable on an adjusted EBITDA basis and has not declared a common dividend). For stocks that fail the screen, the standard treatment is that any distributions require scholar-guided purification — but since Canopy Growth has no dividend, this question is moot for current holders. Consult a qualified scholar for personal rulings.